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Cardiovascular magnetic resonance (CMR) has been shown to provide high quality data on
cardiac and valvular function, perfusion, viability, blood flow, and potentially, on cardiac
metabolism as well. Several of these CMR applications (eg, function and viability assessment)
matured during the past years and are now established components of a cardiac workup.
Perfusion-CMR is close to this status and is already a major contributor to cardiac examinations
in a growing number of expert centers. Large multicenter perfusion-CMR trials comparing the
diagnostic performance of CMR with other techniques were recently reported yielding areas
under the receiver-operator-characteristics curve as a high as 0.85 for coronary artery disease
detection (MR-IMPACT). Anticipating a growing role for perfusion-CMR in cardiology in the
near future, this article discusses the principles of perfusion-CMR and its integration into the
workup of patient with coronary artery disease (CAD). In addition to a functional study, this
integration is mainly composed of a perfusion-CMR part, followed by a viability assessment by
late enhancement CMR techniques. The principal characteristics of these CMR techniques are
compared with those of single photon emission computed tomography (SPECT) and positron
emission tomography (PET). After introduction into principles and techniques of perfusion-
CMR, some open questions in perfusion-CMR and challenges for the future are addressed.
Finally, newer CMR applications are shortly mentioned utilizing hyperpolarized carbon-13
compounds in experimental models for quantification of myocardial perfusion and for real-time
assessment of metabolic pathways in postischemic myocardium. (J Nucl Cardiol 2006;13:
841-54.)a no
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incrFor more than 100 years, cardiovascular disease has
the number one cause of death in the United States,
coronary artery disease (CAD) is by far the most
ortant contributor to this disease burden. Large stud-
sing scintigraphic techniques are the major source of
ence demonstrating the importance of the severity
extent of ischemia for the patients’ prognosis.1-3 In
sands of patients with risk factors but normal scin-
ms, the prognosis is excellent,1,2 which is in line
invasive studies, which showed an event rate of
/y in the mid 1980s for patients with angiograms
stenoses of 50% or less in diameter.4 Taking
antage of the prognostic information provided by the
tigraphic examinations, it was shown that costs for
ent management could be reduced by 30% to 40%
out any compromise in the quality of outcome when
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0.1016/j.nuclcard.2006.09.008ninvasive single photon emission computed tomog-
y (SPECT) approach was applied first in comparison
direct invasive approach.5 These considerations
erline the paramount importance of perfusion assess-
t for patient workup and decision making.
PRINCIPLES OF ISCHEMIA AND VIABILITY
GING: COMPARISON OF CARDIAC MAGNETIC
SONANCE WITH SCINTIGRAPHIC TECHNIQUES
For the assessment of myocardial perfusion, perfu-
–cardiac magnetic resonance (CMR) typically exploits
first-pass kinetics of conventional T1-enhancing extra-
lar gadolinium chelates. This concept has been ap-
d first in animals6-8 and consequently in human
gs.9,10 The magnetic resonance (MR) contrast me-
(CM) enters the microvasculature and also starts to
use within the interstitial space during the first
.11,12 As a result, the signal intensity of the myocar-
increases, the rate of which is linked to the
usion status of the tissue. Accordingly, normally
used myocardium demonstrates a fast signal increase
unit time in the vasodilated state, whereas signal
ease is delayed in myocardium supplied by a criti-841
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only a few seconds, the data acquisition can be
pleted within a breath-hold, which efficiently elimi-
s respiratory motion. In addition, the MR data
ection is electrocardiography (ECG)–triggered,
ch eliminates cardiac motion. Together, breath-hold-
and ECG-triggering preserve the nominally high
ial resolution for perfusion data on the order of 1.5 to
mm  1.5 to 2.5 mm. This excellent spatial resolu-
allows for discrimination of perfusion deficits that
limited to the vulnerable subendocardial layer of
left ventricular myocardium.10,13,14 For compari-
in SPECT imaging technetium 99m–labeled tracers
erally accumulate in viable myocytes in relation to
e perfusion, demonstrating normally perfused myo-
ium as hot tissue, whereas hypoperfused areas ap-
as cold spots similar to the perfusion-CMR situation
ure 1). Once areas with reduced perfusion during
eremia are recognized, it is important to discriminate
operfused scar tissue from hypoperfused but viable
cardium (ie, ischemic tissue). For this purpose, both
R and SPECT imaging are based on the redistribu-
of CM. For CMR, the technique is called late
ancement (LE) or delayed enhancement (DE), and it
sures the accumulation of CM within the expanded
rstitial space present in scar tissue. SPECT measures
redistribution of CM (ie, radiolabeled tracer) into
le myocytes, delineating scar as a cold spot after
-injection or rest-reinjection (Figure 1). For CMR,
conventional gadolinium chelates are excluded from
ct cell membranes and therefore are restricted to a
ll distribution volume of approximately 20% in
le myocardium. In scar tissue and particularly in
e myocyte necrosis the distribution volume may
ease up to 100%.15,16 Consequently, with LE- or
CMR imaging, scar and acute myocardial necrosis
ear as bright tissue. Thus both CMR and SPECT
ging assess perfusion during a vasodilated state (ie,
ss imaging or a CMR stress-only protocol) and
pare hyperemic perfusion data with a reference (ie, a
al database or a normal segment of the studied
t). For viability imaging, both CMR and SPECT
ct scar and necrosis by means of redistribution
ging after a resting (re)injection.
An alternative to the CMR stress-only protocol has
proposed for ischemia detection, in which CMR
usion data acquired during vasodilation are divided
esting perfusion data (stress-rest protocol) to derive
nary flow reserve (CFR).17 This strategy is the
og for the positron emission tomography (PET)
usion approach, in which compromised CFR is
cative of the presence of CAD.10,18-22 For viability
ging, PET is not relying on redistribution of a flow
er but directly probes preserved cellular metabolism,example, by the membrane transport and trapping of
rine 18 fluorodeoxyglucose (FDG). Here, the CFR
cept of CMR (ie, stress-rest protocol) requires addi-
al redistribution imaging—that is, an LE- or DE-CMR
ging approach for viability assessment (Figure 1).
MR and PET example is given in Figure 2. The
og for viability FDG-PET imaging is then the com-
tion of CMR with hyperpolarized carbon 13 com-
nds, which is currently applied successfully in animal
ies.23 With a variety of hyperpolarized C-13 com-
nds, it will be possible to visualize and quantify the
ial metabolic pathways in the myocytes and thereby
haracterize their metabolic state.
For the assessment of myocardial perfusion (ie, the
ction of reduced hyperemic perfusion), 2 CMR
roaches are currently under consideration, involving
er assessment of hyperemic perfusion only (stress-
protocol) or assessment of CFR (stress-rest proto-
. Future studies are warranted to identify the ideal
roach. Whereas the first approach (ie, stress-only
ocol) requires a normal database to provide threshold
es for the hyperemic flow state, the CFR approach
rporates measurements of resting flow. Division of
eremic flow by resting flow may become problem-
, considering that factors such as heart rate, contrac-
, and loading conditions influence resting flow but
difficult to control during a clinical routine examina-
.24 Furthermore, matching myocardial regions for
resting and hyperemic conditions may be difficult
ause the geometry of the heart changes with chang-
heart rate, loading, and so on). Most importantly, the
R technique must guarantee a linear relationship
een MR-derived perfusion parameters and true per-
on over a wide range of conditions (ie, resting and
eremic conditions) to obtain accurate CFR results.
ently, the stress-rest protocol was advocated to help
riminate artifacts from true perfusion deficits,25 in
a signal loss being present on both the rest and stress
usion studies but not matching a bright “scar” signal
E-CMR would indicate the presence of an artifact.
ough such a decision algorithm could be of help in
-quality examinations to detect artifacts, it is clearly
ested to improve the MR pulse sequences to reduce
frequency of artifacts (as also discussed in the
ions entitled “Acquisition of perfusion data by
R” and “Contrast media: Types and doses”). An
ple of a perfusion and anatomic abnormality in a
ent with atypical chest pain is given in Figure 3.
CQUISITION OF PERFUSION DATA BY CMR
netization Preparation
Today, most experience exists for the first-pass
roach involving T1-enhancing MR CM. To increase
Journal of Nuclear Cardiology Schwitter 843
Volume 13, Number 6;841-54 Myocardial perfusion imaging by cardiac magnetic resonanceFigure 1. Mechanisms for CMR imaging considering a T1-weighted sequence and a conventional
T1-enhancing CM (MR CM) (top row), scintigraphy (SPECT) (middle row), and PET (bottom row)
for the assessment of myocardial perfusion (middle column) and viability (right column). In the left
column, the 4 main conditions of myocardium are depicted: normal (nonischemic) myocardium,
ischemic myocardium, and acute necrotic tissue representing acute myocardial infarction (AMI), as
well as its sequelae, chronic scar tissue. In these schematics the extracellular compartment contains
intravascular (plasma) and extravascular space (ie, interstitium). In chronic scar tissue the small
fibrocytes are embedded within a large extracellular (ie, interstitial) space. The middle column
demonstrates perfusion assessment. For CMR, in normally perfused myocardium the MR CM
distributes within the extracellular compartment during the first pass, causing signal increase. In
hypoperfused myocardium first-pass wash-in kinetics is delayed and signal increase is slow. For
SPECT (middle row), radiolabeled tracer is trapped within viable myocytes in relation to perfusion;
that is, less tracer accumulation occurs in hypoperfused, ischemic tissue, which appears as a cold
spot. In scar and acute necrotic tissue slow wash-in occurs for both radiotracer and MR CM. For
viability assessment (right column), equilibrium distribution is required for both radiotracer and MR
CM. For MR CM, the distribution volume in AMI and scar tissue is large, with a consequent high
concentration of MR CM in both necrotic and scar tissue appearing bright on LE-CMR imaging
(with inversion time nulling viable myocardium). For SPECT, radiotracer is not accumulated either
in AMI or in fibrocytes, and necrosis and scar appear as a cold spot (ie, fixed defect), whereas the
radiotracer accumulates in viable myocytes of ischemic myocardium, yielding a hot spot (ie,
reversible defect). Of importance, the combination of perfusion-CMR and LE-CMR is the analog of
the classical combined SPECT stress and redistribution resting study. The combined perfusion-
viability CMR study is short, because equilibrium distribution is typically achieved within 15 to 20
minutes. In addition, data acquisition by CMR lasts only a few seconds, allowing breath-holding and
ECG-triggering to be used, which preserves a high spatial resolution of both the perfusion
and viability CMR data. For ischemia assessment by PET, typically, a stress (ie, hyperemic) study
and a resting perfusion study are performed by use of N-13 ammonia or oxygen 15 water flow
tracers, and a reduced perfusion reserve is indicative of a compromised blood supply to a given
myocardial territory. This PET approach is adopted by the first-pass stress and rest perfusion-CMR
approach (stress-rest protocol), yielding a perfusion reserve index. The viability assessment then
requires an additional LE-CMR study, which corresponds to the FDG-PET study. Whereas
FDG-PET probes glucose transport, hyperpolarized C-13 CM with CMR allows for monitoring (eg,
Krebs cycle) in near real time.
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concentrations, the magnetization may be prepared
re data readout occurs. In the past an inversion
very preparation was most often used,6,8,9,17,26-28
use it provides a large dynamic range of signal
onse, theoretically from negative to positive longi-
nal magnetizations Mz to Mz. However, in prac-
the delay time from preparation to readout was
cted to obtain near-zero magnetization before the
t of readout, which required 300 to 400 milliseconds
Figure 2. An example of a CMR and PET study
First-pass perfusion-CMR (A) demonstrates a larg
the anterolateral, septal, and inferior wall of the le
lateral wall are perfused normally (bright area). Co
(B), only the lateral wall is normally perfused dur
from the perfusion-CMR study, where the normal
derived from receiver operating characteristic curve
D, LE-CMR study in this patient, visualizing sube
anteroseptal region, with a thrombus (black) attach
demonstrates severely reduced FDG uptake (ie, re
scar. F, A polar map is reconstructed from the
subendocardial scar tissue (50% transmurality)
and PET findings are in good agreement with th
strating an occlusion (and collateral channels) of
coronary artery (LAD) (arrows in G), leading to a s
territory of the LAD (D-F) and compromised hyper
(A-C). The inferior and inferoseptal region of com
A through C is caused by an additional stenosis at t
in H). LCX, Left circumflex artery.aiting time, thus precluding true multislice imaging.
refore the currently accepted preparation is a satura-
recovery approach, which renders the signal re-
se independent of heart rate variations and further
tens the waiting time down to 100 to 200 millisec-
s.10,29-35 It should be noted at this point that the
ction of the optimum delay time should not only
mize signal response for the expected changes in
concentration during the first pass but also locate
window for data readout into phases of the cardiac
5-year-old man with atypical chest pain.
ndocardial perfusion deficit (dark area) in
ricle, whereas the subepicardial layer and
ndingly, on the N-13 ammonia PET study
peremia. C, A polar map is reconstructed
for upslope values in each segment were
the detection of50% diameter stenoses).
dial scar tissue (bright) in the anterior and
the infarcted territory. E, F-18 FDG–PET
viability) in the region of subendocardial
R study, visualizing the distribution of
left ventricular myocardium. These CMR
ive x-ray coronary angiography, demon-
oximal and mid left anterior descending
cardial infarction in the core of the supply
ion during vasodilation in the border zones
sed hyperperfusion during vasodilation in
of the right coronary artery (RCA) (arrowin a 5
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Volume 13, Number 6;841-54 Myocardial perfusion imaging by cardiac magnetic resonancee where motion is minimal. Data acquisition in late
ole and mid diastole is typically achieved with a
y time of 100 to 150 milliseconds.10,29
a Readout Strategies
Because the prognosis of patients is dependent on the
nt of perfusion deficits, the aim of perfusion-CMR is to
r the relevant portions of the myocardium. In addition, to
in signal intensity–time curves from which perfusion
meters can be derived, it is suggested to achieve a temporal
lution of 1 stack covering the left ventricular myocardium
g acquired every 1 to 2 RR intervals. These conditions
onstrate that very fast data acquisition is crucial for
usion imaging. One such fast approach is called echo-
ar imaging (EPI), which describes the acquisition of a full
ace (required to reconstruct 1 single image) after a single
frequency excitation. In contrast, with a conventional fast
ient echo approach, 1 radiofrequency excitation is required
Figure 3. Example of images in a 47-year-old m
treadmill test. The first-pass perfusion-CMR stu
hyperperfusion during hyperemia in the subendo
interventricular septum as marked by the arrowhea
the first pass of the CM in the most basal slice is s
right atrium and the right ventricular outflow tract
left ventricular cavity is not contrasted. CM then
washes out of the coronary sinus and right atrium
the rare case of an agenesis of the superior vena
drains into a persistent left superior vena cava, whic
demonstrates the ability of CMR to provide i
high-resolution perfusion information.very line in k-space (eg, 256 excitations for a matrix of
 256). Single shot EPI is very fast, but its relatively long
time renders the sequence prone to susceptibility arti-
.36 Therefore a hybrid-EPI approach appears to be ideal, in
ch 4 to 8 k-lines per radiofrequency excitation are
ired.10,32-34,37 Steady-state free precession pulse se-
nces preserve magnetization and are particularly
ising with respect to a high signal-to-noise ratio
R) but may suffer from other disadvantages because
he relatively long acquisition windows, as shown in
re 4. Alternatively, parallel imaging techniques can
ombined with perfusion imaging.38 These techniques
ire data from folded fields of view and resolve
paround artifacts by taking into account the different
ial sensitivities of various coil elements.39 In general,
llel imaging techniques trade the SNR for speed of
isition. However, meticulous optimization of other
ging parameters can minimize this disadvantage.38
se parallel imaging approaches can be combined with
th rare atypical chest pain and a positive
ows an extensive area of compromised
l layer of the anterolateral wall and the
C). In D through F, the time series during
It demonstrates CM first appearing in the
so in the coronary sinus (D), whereas the
the left ventricular cavity (E) and finally
is sequence of CM arrival is explained by
G). The venous return of the upper body
ly enters the coronary sinus. This example
nt anatomic information in addition toan wi
dy sh
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ds (A-
hown.
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space, which results in even higher acceleration
ors. Techniques such as k-t BLAST (Broad-use
ar Acquisition Speed-up Technique) and k-t SENSE
NSitivity Encoding)40 achieve high acceleration fac-
but might demonstrate higher susceptibility to mo-
and could smooth temporal information. Thus future
ies will be needed to assess the potential of these
er techniques.
Besides selection of the optimal pulse sequence for
perfusion data acquisition, the imaging parameters
given pulse sequence are crucial with respect to the
Figure 4. Effect of different MR pulse sequence
spin-echo image on the left (A) represents a hear
concentrations of a conventional extracellular gado
the core of the phantom mimicking the left ven
concentrations mimicking normal and hypoperfu
seconds) are given in B. High image quality is o
(ssfp) pulse sequence (acquisition window, 212
non–slice-selective 90° preparation; readout flip an
Netherlands) (C), which degrades steadily with inc
(motion 1 and 2 in D and E, respectively). Conve
window, 91 milliseconds; spatial resolution, 3 
readout flip angle, 30°) shows moderate quality a
with increasing motion (G and H). This example d
in the signal-CM concentration relationship but c
induced artifacts. Phantom measurements were pe
Luechinger, PhD, and Sebastian Kozerke, PhD, In
Institute of Technology, Zurich, Switzerland.and contrast-to-noise ratio (CNR), spatial and
poral resolution, and cardiac coverage. It could be
onstrated that for a given hybrid-EPI pulse sequence,
signal change during the first pass can range from
up to 280% of baseline signal, which translated into
cceptable diagnostic performance for the optimized
ging parameters, yielding a sensitivity and specificity
2% and 73%, respectively, for detection of stenoses
0% or greater in diameter (for transmural data),
reas the original pulse sequence37 yielded a clinically
useful performance, with a sensitivity and specificity
1% and 43%, respectively.29
erfusion imaging on image quality. The
om containing compartments of different
chelate, with the highest concentration in
blood pool and compartments of lower
yocardium. Corresponding T1 values (in
by use of a steady-state free precession
econds; spatial resolution, 3  3 mm2;
°; 1.5 T) (Philips Medical Systems, Best,
combined translational-rotational motion
a hybrid-EPI pulse sequence (acquisition
m2; non–slice-selective 90° preparation;
F), which does not deteriorate, however,
trates that pulse sequences not only differ
differ in their susceptibility for motion-
d together with Salome Ryf, PhD, Roger
of Biomedical Engineering of the Federals for p
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Because fast imaging is inherently coupled to a lower
, a higher field strength is theoretically advantageous.
resent, very limited data on perfusion-CMR at 3 T are
lable, whereas all larger studies and, in particular, all
ticenter trials are performed on 1.5-T magnets.33,34,41 In
all study by Araoz et al42 the CNR between baseline
peak contrast at 3 T was superior to 1.5 T. However, the
at 3 T was less homogeneously distributed within the
ventricular myocardium with a lower ratio in the
rior wall. This part of the heart is typically exposed to
e magnetic field inhomogeneities, which appear more
ant at 3 T.
CONTRAST MEDIA: TYPES AND DOSES
avascular CM
For scintigraphic techniques, there is a well-defined
tionship between tracer activity and tracer concentra-
(when the tracer decay time is considered), which is
reason for PET to generate quantitative results on
usion and metabolism. For SPECT imaging, the
al (ie, tracer activity) and tracer amount are linear,
gh distorted to some extent by attenuation and
ter. For CMR, the relationship between the MR
al and the CM concentration is not linear. For
nhancing CM, the signal increases with increasing
centrations up to a maximum and declines thereafter
igher CM concentrations.43 In addition, the shape of
curve is dependent on the pulse sequence and
ging parameters. For example, at lower T1-enhancing
centrations of a conventional gadolinium chelate,
cardial signal increases during the first pass when
ired with a T1-weighted pulse sequence, delineating
operfused myocardium as dark areas. Conversely, at
er concentrations of the same CM, signal acquisition
a T2-weighted pulse sequence causes a signal drop
ng the first pass, delineating hypoperfused myocar-
as bright tissue.44 In addition, the distribution
ern of CM within the myocardium may affect the
al generation. Saeed et al took advantage of this
nomenon and could demonstrate a loss of cell mem-
e integrity using a dysprosium chelate combined
a T2*-weighted pulse sequence.45 When concentrat-
on the gadolinium chelates, which are currently the
t important MR CM for clinical applications, we
e to consider their mechanism of action. Gadolinium
ates facilitate relaxation (ie, recovery of longitudinal
netization) by interaction with the surrounding water
ons. This implies that, for example, gadolinium
ates outside the cellular compartment influence the
rcellular concentration of relaxed water protonsugh proton exchange over the cellular membrane.
ides the cellular membranes, the capillary vessel wall
ngly affects the signal generation.46 Exchange con-
ns are categorized into fast, intermediate, and slow.
water exchange exists if the rate of water exchange
een compartments is considerably higher than the
erence in the longitudinal relaxation rate between the
partments in the presence of CM, and consequently,
ges in the tissue relaxation rate reflect changes in the
d relaxation rate.47-49 This is in contrast to the slow
vascular-extravascular water exchange, which is the
-limiting step for signal generation in tissue (slow
ange regimen).47-49 Thus neglecting water exchange
intravascular CM can result in considerable errors in
usion measurements (for more details, see also ref-
ce 12). These considerations may demonstrate that
iction of signal response during the first pass in
eremic tissue by mathematic models is a difficult task
simulations will not be able to replace experiments
re true signal responses for different CM types and
s are quantified.
The effect of increasing doses of a conventional
acellular gadolinium chelate (Gd–diethylenetriamine
taacetic acid [DTPA]) on myocardial signal response
recently evaluated in a multicenter single-vendor
y using the same hybrid-EPI pulse sequence on all
hines.33 With doses starting at 0.05 mmol/kg body
ght and increasing to 0.10 and 0.15 mmol/kg, an
easing signal response was observed with relative
eases from baseline of approximately 100%, 200%,
280%, respectively. In agreement with an earlier
le-center study,29 a signal increase of about 100% in
multicenter study yielded an unacceptable diagnostic
ormance, with an area under the receiver operating
acteristic curve (AUC) of 0.51  0.13. Where high
ients of magnetization within the imaging volume
r, dephasing of the magnetization is increased and a
al loss is observed. Such high gradients of magneti-
on may build up at the blood pool–subendocardial
rface during the first pass, when CM concentrations
high in the blood pool but are still low in the
cardium. This situation could cause cumbersome
es of signal loss at the subendocardial layer mimick-
subendocardial hypoperfusion. This type of signal
is called susceptibility artifact and might be propa-
d by high CM concentrations. It was therefore
ortant to note that even at 0.15 mmol/kg of Gd-
A combined with a hybrid-EPI acquisition, no
surable signal loss and, consequently, no reduction
ubendocardial upslope values were observed.33 Thus
and 0.15 mmol/kg provided the advantage of a high
al change during the first pass without causing a
surable susceptibility artifact, resulting in an excel-
AUC of 0.88  0.05 for the detection of CAD
defi
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ntitative coronary angiography. Similarly, doses from
up to 0.10 mmol/kg Gd-DTPA–bismethylamdie
A) were evaluated in a multicenter, multivendor
ng.41 This study, called MR-IMPACT (Magnetic
onance Imaging for Myocardial Perfusion Assess-
t in Coronary artery disease Trial), is the largest
usion-CMR trial performed thus far; it was per-
ed in 18 centers worldwide and yielded the best
nostic performance for the highest dose of 0.10
ol/kg, with an AUC of 0.85  0.06.41 These multi-
er trials33,41 and others10 indicate that doses of
roximately 0.10 mmol/kg body weight of a gadolin-
chelate for first-pass perfusion studies provide ap-
riate diagnostic performance.
avascular CM
These contrast media remain in the intravascular
e during the first pass. However, as pointed out
iously, they address extravascular water protons and
therefore not “pure” intravascular contrast media. In
ition, even during brief episodes of ischemia, endo-
ial leakage occurs,50 which “transforms” such intra-
ular contrast media into extravascular contrast me-
It is well known from experimental51 and clinical
ies52 that during vasodilation, steal phenomena can
ce ischemia; however, it might be difficult to iden-
these areas a priori, with the consequence that
els considering these effects are difficult to design.53
ertheless, T1-enhancing intravascular contrast media
as albumin-targeted MS-32554 or polylysine gado-
m55 have been successfully applied in animal mod-
Further testing in human beings is of course neces-
for final assessment of the potential of intravascular
for perfusion imaging. Intravascular superparamag-
c iron oxide nanoparticles (ultrasmall superparamag-
c iron oxide) in combination with a T2-weighted
o spin-echo sequence were also used for perfusion
ies in human beings, causing a signal drop in
ally perfused myocardium.56 However, these com-
nds are no longer under evaluation because of CM
mulation in the liver.
erpolarized C-13 CM
At thermal equilibrium at a field strength of 1.5 T,
MR-active nuclei (ie, water protons) are present at
approximately 5 ppm, because of the very low
rization level. Thus the conventional gadolinium
ates are only acting on this low concentration of
s, which can be doubled by increasing the field
ngth to 3 T. Newer techniques now allow the polar-
ion level of specific nuclei such as liquid C-13 inous compounds to be increased by a factor of up to
,000 (compared with polarization of water protons at
mal equilibrium). Techniques for hyperpolarization
known as para-hydrogen–induced hyperpolariza-
57 and dynamic nuclear polarization.58 Para-hydrogen–
ced hyperpolarization uses simpler equipment and is
but is only applicable to smaller C-13 molecules,
reas dynamic nuclear polarization can be applied to
uclei (hydrogen 1, C-13, nitrogen 15, and so on).
polarization degree of approximately 30% translates
a tremendous increase in signal if appropriate MR
e sequences are applied. Unlike gadolinium chelates,
erpolarized C-13 contrast media do not accelerate the
xation rate of water protons, but the MR signal is
ctly emitted by the hyperpolarized C-13 CM. Con-
ently, no background signal would be acquired in
usion studies, and most importantly, these hyperpo-
ed C-13 contrast media act as pure intravascular
trast media, which would allow for easier quantifica-
of perfusion. However, because the spin population
-13 molecules is far away from thermal equilibrium,
itudinal magnetization decays with specific time
stants (depending on the type of C-13 compound),
ch must be taken into account, similarly to radio-
er decay. In addition, depolarization as a result of
titive radiofrequency pulsing has to be considered,
ch further destroys longitudinal magnetization. Jo-
sson et al59 showed that depolarization can be ap-
imated by a monoexponential function and success-
applied this concept for cerebral perfusion
ntification. So far, these contrast media are only
lied in animal experiments,59 but preliminary results
encouraging. An example of a cardiac perfusion
y using an intravascular C-13 compound is given in
re 5.
PERFUSION DATA ANALYSES
This overview on technical aspects of perfusion-
R together with the varieties in CM types and doses
rly demonstrates that perfusion-CMR today is not a
le technique but is a rapidly evolving field of
arch, which now enters the clinical arena. It is
efore not surprising that this broad spectrum of
usion-CMR is reflected in a similarly large spectrum
ttempts to analyze the perfusion data. While the
ocol (stress-only vs stress-rest) and the best MR
e sequence with its optimum imaging parameters, as
l as its appropriate CM type and dose, are not yet
rely established, the same holds for the data analyses
ently proposed. To support development in the field
erfusion-CMR, it appears highly desirable to estab-
some common definitions. This would allow for
ct comparison of the results of novel approaches or
mod
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ifferent publications. For this purpose, a visual
ssment of perfusion data would not be adequate,
use the inter-reader variability for visual assessment
been reported to be substantial, with  values as low
.30.34 Therefore two categories of assessment are
osed: (1) visual and (2) quantitative. The quantita-
analysis is then further categorized into (1) quanti-
tion of perfusion-related parameters and (2) absolute
ntification of perfusion (in milliliters per minute per
of tissue). Whereas absolute quantification of
usion is still challenging and not all issues are
lved, the quantification of perfusion-related parame-
appears best suited to serve as an interstudy standard.
usion-related parameters have been applied widely
Figure 5. Perfusion assessment by hyperpolarize
shown in A through H demonstrating the wash-in
C-13 compound in a pig. Because signal obtained
concentration (considering T1-relaxation and sign
model is applicable to the signal intensity–time cu
pixel-wise and represented by a color-coded perf
represents a mean myocardial blood flow at rest
conventional H-1 proton image. To obtain this ty
must be of a send-and-transmit type at the C-13
compared with approximately 60 MHz for proton i
Klaes Golman, PhD, GE Healthcare, Malmö, Sweare, for example, the upslope of signal during
-pass conditions,7,10,13,14,17,26,29,33 the maximum sig-
during the first pass,6,8,14,54,60 the time to peak, the
n transit time,7,14,53 the area under the signal inten-
–time curve,61 and many others. Before an analysis
rithm is applied, the perfusion data are typically
stered—that is, motion resulting from a drift of the
hragm or even from breathing is eliminated by
ting the images in the time series, which can be
eved by hand or by means of algorithms. With this in
d, it is obvious that the definition of the two catego-
for a quantitative analysis (perfusion-related and
lute perfusion) is not sufficient. It should be further
ned how the data were extracted from the images: (1)
ual, (2) semiautomatic (ie, some observer interfer-
CMR. A time series of C-13 images is
s during the first pass of an intravascular
e C-13 compound is linearly related to its
y as result of pulsing), the Kety-Schmidt
), and myocardial perfusion is calculated
map (I). This color-coded perfusion map
mL · min1 · g1 and is overlayed on a
ombined image, the radiofrequency coils
ncy of approximately 15 MHz (at 1.5 T)
. (Courtesy of Stefan Petersson, PhD, andd C-13
kinetic
from th
al deca
rves (J
usion
of 0.98
pe of c
freque
maging
den.)
ence
inte
sem
“per
qua
data
effo
algo
app
data
upd
ima
han
resu
vari
obje
cov
reci
betw
man
app
(min
AU
virtu
with
prod
but
Acc
esta
rithm
qua
set
diag
mul
man
mm
0.91
low
qua
izat
CM
cost
V
dete
stag
que
Unf
Inst
infa
com
tect
char
(ie,
gen
at r
The
ity i
ticu
tion
dist
duri
mat
mm
this
is c
tech
syst
ima
inte
the
1 to
disc
are
basi
dist
in p
that
that
rim
4
men
segm
LE-
enti
regi
tary
tion
wel
skel
pho
high
ope
Hyp
mai
tific
pou
the
or t
high
obta
850 Schwitter Journal of Nuclear Cardiology
Myocardial perfusion imaging by cardiac magnetic resonance November/December 2006with the images), or (3) automatic (ie, no observer
rference with the images). In this context the term
iquantitative may be misleading, because it can mean
fusion-related” (although the result is given in a
ntitative measure) or it can simply describe the way
were extracted (eg, semiautomatic).
Regarding the analysis of perfusion data, many
rts are still needed to define the most adequate
rithms. It should be noted that for all analysis
roaches that are based on comparisons with a normal
base, such normal databases would need to be
ated when new hardware or software is installed or
ging parameters are changed. Although this is a
dicap compared with visual reading, a quantitative
lt of perfusion studies would minimize observer
ability and would allow the activity of CAD to be
ctively monitored over time.
Perfusion data analysis cannot be addressed without
ering the issue of data quality. There is clearly a
procal relationship for a given analysis algorithm
een its “automaticity” and its diagnostic perfor-
ce. In other words, a fully automatic algorithm
lied to high-quality data is likely to perform well
imum number of nonevaluable studies and high
C compared with a standard of reference), with
ally absent observer variability. On the other hand,
low-quality data, a high number of failures will be
uced, and a manual analysis would perform better
at the cost of observer dependence in the latter case.
ordingly, it will be a major task in the future to
blish criteria or, even better, computerized algo-
s that would define data quality. Categories of
lities would then be available qualifying a given data
for a particular analysis algorithm for which the
nostic performance is known. In a single-vendor
ticenter trial, for example, the diagnostic perfor-
ce of perfusion-CMR with an AUC of 0.72 (at 0.1
ol/kg Gd-DTPA) for CAD detection was increased to
when eliminating 14% of all studies that were of
quality and including only the central 3 (high-
lity) slices in the analysis algorithm.33 Such standard-
ions are deemed crucial if the impact of perfusion-
R in cardiology should increase and estimations of
-effectiveness should become available.
IABILITY AND METABOLIC IMAGING BY CMR
Monitoring CAD activity by perfusion-CMR would
ct ischemia and thus the patient at risk in an early
e. This would allow for interventions and conse-
ntly the avoidance of infarctions in the ideal case.
ortunately, this ideal situation is still far away.
ead, the number of patients with a mixture of chronic
rctions and ischemia is increasing. Accordingly, aplete workup of CAD patients clearly requires de-
ion of hypoperfusion (during hyperemia) and its
acterization as being either present in viable tissue
ischemic tissue during conditions of increased oxy-
demand or hibernating tissue with reduced function
est) or present in nonviable tissue (ie, scar tissue).
refore perfusion-CMR should be followed by viabil-
maging when hypoperfused areas are detected, par-
larly if these hypoperfused areas show reduced func-
at rest. As shown in Figure 1, CMR probes the
ribution volume of conventional gadolinium chelates
ng steady-state conditions, which occur approxi-
ely 15 to 20 minutes after injection of 0.15 to 0.25
ol/kg intravenously.62 Stressing the need to wait for
steady-state condition to occur, the CMR technique
alled either an LE- or DE-CMR technique. This
nique is less demanding with respect to the gradient
em of the scanner, because the time window for
ging lasts several minutes (compared with 1-2 RR
rvals for perfusion-CMR), which allows coverage of
entire heart with a spatial resolution on the order of
2 mm  1 to 2 mm. This high spatial resolution
riminates small subendocardial scar regions,63 which
not detectable by PET62,64 or SPECT65 on a regular
s. This detailed insight into the transmural scar
ribution was analyzed to predict functional recovery
atients after revascularization.62 It was demonstrated
both conditions must be met for functional recovery—
is, sufficient viable rim tissue (approximately4.5 mm
thickness) and no or small scar tissue (approximately
mm). This study also showed that mismatch seg-
ts on FDG-PET imaging were most prevalent in
ents with a substantial rim of viable tissue on
CMR, indicating that mismatch segments are prefer-
ally encountered in the subepicardial layer of scar
ons. Thus CMR and PET can provide complemen-
information, but CMR may add metabolic informa-
to functional, perfusion, and viability information as
l. Although MR spectroscopy of the heart66 and
etal muscle67 is feasible to quantify high-energy
sphates, it may not access all parts of the heart with
resolution. Here, hyperpolarized C-13 CM may
n a new chapter in metabolic imaging.
erpolarized C-13 CM
Whereas some hyperpolarized C-13 compounds re-
n intravascular and can be used for perfusion quan-
ation (Figure 5), other hyperpolarized C-13 com-
nds may act to trace the citric acid cycle to determine
oxygen consumption of the cell, to measure the pH,
o trace other metabolites within the cells. Given the
signal available, this metabolic information can be
ined with millimeter resolution updated every few
seco
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el spectra can be acquired that allow for identification
quantification of several different compounds simul-
ously by use of chemical shift imaging or even faster
roaches such as multiecho steady-state free preces-
pulse sequences.23 Because the resonance frequency
e metabolic products of, for example, C-13-pyruvate
ufficiently separated from the frequency of C-13-
vate itself, it is possible to trace the C-13 atom
ugh the various metabolic and catabolic pathways in
cells in vivo.23 This is different from PET imaging,
ch visualizes the active nuclei irrespective of whether
are still contained in the injected tracer. Thus
itoring the fate of C-13-pyruvate into its metabolites,
3-alanine and C-13-lactate, is possible in near–real-
imaging, whereas the tissue concentration of C1-
vate is a measure of tissue perfusion. In addition, a
concentration of HCO3 is indicative of a low
onal tissue pH (pH-dependent CO2↔HCO3 equi-
Figure 6. Metabolic assessment by hyperpolarized
ized C-13-pyruvate was injected intravenously at b
monitor the metabolism of C-13-pyruvate into C
shown in the upper row (A-D). Conventional proto
and LE imaging for assessment of viability were al
was subjected to 15 minutes of left circumflex c
catheter. After 2 hours of reperfusion, it was aga
injection of hyperpolarized C-13-pyruvate (lowe
pyruvate is represented in all myocardial segments
(E), metabolic imaging demonstrates a severe red
territory of the lateral wall (G) whereas C-13-lacta
without a notable change in C-13-alanine (H). This
the Krebs cycle) is detected 2 hours after a relati
demonstrating the phenomenon of metabolic mem
Klaes Golman, PhD, GE Healthcare, Malmö, Sweum). Whereas hibernation might represent a mecha-
to downregulate function to preserve tissue struc-
and cell homeostasis, it was hypothesized that after
ischemic insult, cellular metabolism might change
ard anaerobic energy production to preserve cell
tion. If this is true and changes would persist, this
tive change of metabolism would represent a kind of
abolic memory. The presence of metabolic memory
emonstrated by use of C-13 metabolic CMR imaging
igure 6, where metabolic alteration of the citric acid
bs) cycle was demonstrated 2 hours after a short
emic insult of 15 minutes’ duration.
FUTURE PERSPECTIVES OF PERFUSION-CMR
In the past few years considerable improvements
e achieved in the treatment of CAD, particularly
the invention of drug-eluting stents, which re-
ed the rate of in-stent restenoses considerably.
CMR. In this pig experiment hyperpolar-
e, and chemical shift imaging was used to
ctate, C-13-alanine, and bicarbonate, as
ing for assessment of contractile function
ormed. After baseline imaging, the animal
y artery occlusion by an inflated balloon
ied by C-13 chemical shift imaging after
[E-H]). Although hyperpolarized C-13-
t baseline (A) and after the ischemic insult
in bicarbonate in the formerly ischemic
tent is increased in the same territory (F),
e in the metabolism of C-13-pyruvate (ie,
hort ischemic period of only 15 minutes,
(Courtesy of Stefan Petersson, PhD, andC-13
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entions performed in the setting of acute coronary
dromes, changed the outcome of these high-risk
ents. Nevertheless, about 40% of patients having
cute coronary attack die from it, most of them in
preclinical phase or in the emergency department
re undergoing a rescue percutaneous coronary
rvention,68 indicating that the identification of
-risk patients with currently established guide-
s is not optimal. The increasing number of SPECT
ies in the past years demonstrates the need for a
invasive approach to identify the patients at risk,
approximately half of them being asymptomatic
re cardiac death.68 Therefore a shift is likely to
ur from a “reactive” strategy, where patients with
ptoms predominantly undergo further diagnostic
kup, to an “active” strategy, where patients will
ergo additional noninvasive investigations accord-
to their risk profile. For such an “active” strategy,
usion-CMR would be ideally suited, because large
ticenter studies have demonstrated a good diag-
tic performance of the technique.33,41 It is repeat-
and safe, and costs are expected to be similar to
s of other noninvasive techniques. Substantial data
available for SPECT demonstrating its cost-effec-
ness,5 and it is hoped that such data will soon be
ilable for the CMR technique as well. As pointed
previously, considerable efforts will be needed in
near future to standardize the perfusion-CMR
ocols, the pulse sequences, and the analysis meth-
. In a next step the performance of the various
nostic techniques should be compared in prospec-
trials to identify the best indications for each
nique. For the successful conduction of future
parative studies, close cooperation between the
esentatives of the various techniques in noninva-
cardiology will be crucial.69 It will then be an
oing challenge to adapt the established guidelines
diagnostic workup.
Of course, for an “active” strategy, the following
stion has to be addressed: At which level of risk
uld an individual patient undergo a diagnostic
kup?70 In addition to the classical cardiovascular
factors, the risk of an individual patient could be
her characterized by plaque imaging, by probing
endothelial function (eg, by sophisticated MR
niques),71 by hyperpolarized C-13 CM metabolic
ging, or by screening the genome.72 (However, the
ber of candidate genes associated with cardiovas-
r diseases is extremely high, making a distinction
een random and true biologic associations diffi-
.) A combination of these various aspects of
ular disease will be most promising in identifying
patients who will benefit most from early riskagement and a monitoring strategy of CAD activ-
to determine the optimum time point for coronary
rventions before infarctions occur.
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